Literature DB >> 33328002

[Clinical features of children with recurrent Kawasaki disease: a Meta analysis].

Gang Luo1, Si-Lin Pan1, Si-Bao Wang1, Zhan-Hui DU1, Zhi-Xian Ji1.   

Abstract

OBJECTIVE: To study the clinical features of children with recurrent Kawasaki disease (KD).
METHODS: PubMed, Web of Science, Embase, CNKI, Wanfang Med Online, and Weipu Data were searched for case-control studies on the clinical features of initial and recurrent KD. The articles were screened according to the inclusion and exclusion criteria. RevMan 5.3 software was used to perform the Meta analysis. Effect models were selected based on the results of heterogeneity test, and then pooled OR or weighted mean difference (WMD), and their 95% CI were calculated.
RESULTS: A total of 9 case-control studies were included, with 12 059 children with KD in total, among whom 206 children had recurrent KD (127 boys/61.7%; 79 girls/38.3%). The results of the Meta analysis showed that compared with the initial KD onset, the children with recurrent KD had a shorter duration of fever (WMD=-1.81, 95%CI:-2.99 to -0.64) and a lower proportion of children with swelling of the hands and feet (OR=0.46, 95%CI:0.26 to 0.80). There was no significant difference in the incidence rate of coronary artery lesions between recurrent KD and initial KD (OR=1.34, 95%CI:0.84 to 2.14).
CONCLUSIONS: Current evidence shows that children with recurrent KD tend to have a shorter duration of fever and a lower incidence of swelling of the hands and feet. KD recurrence is more common in boys. Current evidence does not show an increased risk of developing coronary artery lesions in children with recurrent KD.

Entities:  

Mesh:

Year:  2020        PMID: 33328002      PMCID: PMC7735929     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  15 in total

1.  Recurrence of coronary artery lesions after complete regression in a peculiar case of Kawasaki disease.

Authors:  Shiv D Sharma; Kanupriya Chaturvedi; Avesh Saini; Swatantra Rathore; Mohit Tayal
Journal:  Cardiol Young       Date:  2019-04-30       Impact factor: 1.093

2.  A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population.

Authors:  Tohru Kobayashi; Shigeto Fuse; Naoko Sakamoto; Masashi Mikami; Shunichi Ogawa; Kenji Hamaoka; Yoshio Arakaki; Tsuneyuki Nakamura; Hiroyuki Nagasawa; Taichi Kato; Toshiaki Jibiki; Satoru Iwashima; Masaru Yamakawa; Takashi Ohkubo; Shinya Shimoyama; Kentaro Aso; Seiichi Sato; Tsutomu Saji
Journal:  J Am Soc Echocardiogr       Date:  2016-06-07       Impact factor: 5.251

3.  Clinical features of recurrent Kawasaki disease and its risk factors.

Authors:  Hai-ming Yang; Zhong-Dong Du; Pei-pei Fu
Journal:  Eur J Pediatr       Date:  2013-07-26       Impact factor: 3.183

4.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

5.  Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada.

Authors:  Nita Chahal; Zeeshanefatema Somji; Cedric Manlhiot; Nadia A Clarizia; Justin Ashley; Rae S M Yeung; Brian W McCrindle
Journal:  Pediatr Int       Date:  2012-06       Impact factor: 1.524

6.  Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years.

Authors:  Daisuke Sudo; Yosikazu Nakamura
Journal:  Acta Paediatr       Date:  2017-02-26       Impact factor: 2.299

Review 7.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

8.  Resistance to intravenous immunoglobulin in children with Kawasaki disease.

Authors:  Adriana H Tremoulet; Brookie M Best; Sungchan Song; Susan Wang; Elena Corinaldesi; Julia R Eichenfield; Danielle D Martin; Jane W Newburger; Jane C Burns
Journal:  J Pediatr       Date:  2008-03-04       Impact factor: 4.406

9.  [Clinical features of recurrent Kawasaki disease in 20 children].

Authors:  Li-Xia Zou; Fang-Qi Gong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2008-10

10.  Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Izumi Chihara; Yasuko Aoyama; Kazuhiko Kotani; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2010-06-05       Impact factor: 3.211

View more
  1 in total

1.  Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease.

Authors:  Xi Chen; Lu Gao; Zhen Zhen; Ying Wang; Jia Na; Wen Yu; Xinyuan Chu; Yue Yuan; Suyun Qian
Journal:  J Inflamm Res       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.